Claim Missing Document
Check
Articles

Prediktor Keberhasilan Terapi Obat Anti Tuberkulosis (OAT) Pada Pasien TBC di Puskesmas Masaran 2 Vanesha Aida Rahma Viona; Niken Luthfiyanti; Bagas Ardiyantoro
KOLONI Vol. 5 No. 3 (2026): SEPTEMBER 2026
Publisher : Universitas Pahlawan Tuanku Tambusai

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.31004/koloni.v5i3.1352

Abstract

Tuberculosis (TB) remains a major public health problem in Indonesia, with Central Java among the five provinces with the highest case burden. The success of TB treatment is influenced by various predictive factors, both sociodemographic and clinical, which need to be identified to optimize therapeutic outcomes. This study aimed to determine the predictors associated with the success of Anti-Tuberculosis Drug (ATD) therapy in TB patients at Puskesmas Masaran II and to identify the most influential factor. This was a non-experimental study using a cross-sectional approach, with data collected retrospectively from the medical records of TB patients during the period of May 2023–May 2026. The sample was determined using the Slovin formula with a purposive sampling technique, resulting in 71 patients who met the inclusion and exclusion criteria. Data were analyzed univariately and bivariately using the Chi-Square test (α = 0.05), with associations expressed as Odds Ratios (OR) and 95% confidence intervals. A total of 45 patients (63.4%) achieved negative sputum smear conversion by the fifth month, while 26 patients (36.6%) failed to convert. Of the 14 variables tested, six were significantly associated (p < 0.001) with treatment success: drug side effects, nutritional status, treatment regimen, patient category, drug resistance, and comorbidities. Drug side effects showed the strongest association (OR = 23.062; 95% CI: 6.148–86.507). These six factors are important predictors of ATD therapy success in TB patients at Puskesmas Masaran II.
Potensi Flavonoid dari Ekstrak Etil Asetat Daun Kembang Bulan (Tithonia Diversifolia) Sebagai Inhibitor α-Amilase: Studi in Vitro untuk Pengembangan Antidiabetes Adelino Gusmao; Niken Luthfiyanti; Danang Raharjo
Borneo Nursing Journal (BNJ) Vol. 8 No. 2b (2026)
Publisher : Akademi Keperawatan Yarsi Samarinda

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.61878/bnj.v8i2b.1675

Abstract

Latar Belakang: diabetes melitus merupakan gangguan metabolit kronis yang ditandai peningkatan kadar glukosa darah akibat gangguan sekresi atau sensitivas insulin. Penghambatan enzim α-Amilase dapat membantu mengendalikan peningkatan glukosa darah setelah makan melalui penghambatan pemecahan karbohidrat. Daun kembang bulan (Tithonia Diversifolia) mengandung metabolit sekunder, termasuk flavonoid, yang diduga berpotensi sebagai antidiabetes. Tujuan: Penelitian ini bertujuan mengidentifikasi metabolit sekunder, menentukan kadar flavonoid total, serta mengetahui aktivitas ekstrak etil asetat daun kembang bulan dalam menghambat enzim α-Amilase secara in Vitro. Metode: Penelitian dilakukan secara eksperimental. Daun kembang bulan diekstraksi dengan metode maserasi menggunakan pelarut etil asetat. Analisis meliputi skrining fitokimia, penepatan kadar flavonoid total dengan metode AlCl3, menggunakan kuersetin sebagai pembanding, serta pengujian penghambatan α-Amilase menggunakan metode DNS dengan akarbose sebagai kontrol positif. Aktivitas ditentukan berdasarkan nilai IC₅₀. Hasil: Skrining fitokimia menunjukkan adanya flavonoid, alkaloid, saponin, tanin, dan terpenoid. Kadar flavonoid total diperoleh sebesaar 32,120 ± 2,245 mg ekstrak. Ekstrak mampu menghambat aktivitas α-Amilase dengan niai IC₅₀ sebesar 76,59 ppm, yang termasuk kategori penghambatan kuat. Kesimpulan: Ekstrak etil asetat daun kembang bulan (Tithonia Diversifolia) penghambatan α-Amilase yang kuat. Nilai IC₅₀ sebesar 76,59 ppm menunjukkan bahwa ekstrak berpotensi dikembangkan sebagai sumber bahan alam kandidat antidabetes.
FACTORS INFLUENCING MEDICATION BELIEFS AMONG HYPERTENSIVE PATIENTS AT NGEMPLAK BOYOLALI COMMUNITY HEALTH CENTER IN 2026 Aprilia Puteri Santika; Tri Novita Wulandari; Niken Luthfiyanti; Rahmat Hidayat
Proceeding of the International Conference Health, Science And Technology (ICOHETECH) 2026: Proceeding of the 7th International Conference Health, Science And Technology (ICOHETECH)
Publisher : LPPM Universitas Duta Bangsa Surakarta

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.47701/xz9v5w15

Abstract

Hypertension requires long-term treatment to control blood pressure and prevent complications. Adherence to this therapy is influenced by medication beliefs—specifically, patients' perceptions regarding the necessity of the medication and concerns about its use. Given that these perceptions impact quality of life, it is important to analyze the factors influencing the medication beliefs of hypertensive patients at the Ngemplak Boyolali Community Health Center in 2026. Objective: This study aimed to analyze the factors influencing medication beliefs among patients with hypertension at Ngemplak Public Health Center, Boyolali, in 2026. Methods: This cross-sectional, quantitative analytical observational study evaluated 92 hypertensive patients meeting the inclusion criteria at Ngemplak Public Health Center, Boyolali, in 2026. The Beliefs about Medicines Questionnaire (BMQ) assessed medication beliefs, while a structured questionnaire recorded potential influencing factors. Statistical relationships were examined via the Chi-Square test ( = 0.05). Results: The results showed that most respondents were aged 36–55 years (75.0%), female (64.1%), educated up to elementary school (59.8%), others therapy (94.6%), and had hypertension for less than 5 years (73.9%). Statistical analysis revealed no significant relationships between medication beliefs and age (p = 0.614), gender (p = 0.680), education level (p = 0.737), or disease duration (p = 0.815). Conversely, others therapy was identified as a significant factor associated with medication beliefs (p = 0.020). Conclusion: Among evaluated factors, others therapy significantly influenced medication beliefs in hypertensive patients at Ngemplak Community Health Center in 2026. Tailored counseling, healthcare provider support, and family engagement are recommended to optimize patient adherence.  
Hubungan Medication Beliefs dengan Kualitas Hidup pada Pasien Hipertensi di Puskesmas Ngemplak Boyolali Tri Nofita Wulandari; Niken Luthfiyanti; Rahmat Hidayat
OBAT: Jurnal Riset Ilmu Farmasi dan Kesehatan Vol. 4 No. 6 (2026): November: OBAT: Jurnal Riset Ilmu Farmasi dan Kesehatan
Publisher : Asosiasi Riset Ilmu Kesehatan Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.61132/obat.v4i6.2627

Abstract

Hypertension is a chronic condition requiring long-term treatment to control blood pressure and prevent complications. Patients’ perceptions of the necessity of their medication and concerns about its use, collectively known as medication beliefs, may influence their treatment experience and quality of life. This study aimed to determine the relationship between medication beliefs and quality of life among hypertensive patients treated at Ngemplak Public Health Center, Boyolali, in 2026. A cross-sectional design was applied to 92 hypertensive patients who met the inclusion criteria. Medication beliefs were assessed using the Beliefs about Medicines Questionnaire (BMQ), while quality of life was measured using the WHOQOL-BREF. The relationship between the two variables was analyzed using the Chi-Square test. Positive medication beliefs were found in 52 respondents (56.5%), followed by negative beliefs in 29 respondents (31.5%) and neutral beliefs in 11 respondents (12.0%). Regarding overall quality of life, 77 respondents (83.7%) had high quality of life and 15 respondents (16.3%) had moderate quality of life; none had low quality of life. The Chi-Square test showed no statistically significant relationship between medication beliefs and quality of life (p=0.324; p>0.05). In conclusion, no significant relationship was found between medication beliefs and quality of life among hypertensive patients at Ngemplak Public Health Center, Boyolali, in 2026, within the study population overall. Further research should examine other factors, including therapy type, adverse drug reactions, medication adherence, and family support.
Evaluasi Pola Penggunaan dan Rasionalitas Terapi Stroke Iskemik Terhadap Outcome Klinis di RSUD Dr. Moewardi Surakarta Alia Riski Andriyani; Niken Luthfiyanti; Anna Fitriawati
OBAT: Jurnal Riset Ilmu Farmasi dan Kesehatan Vol. 4 No. 6 (2026): November: OBAT: Jurnal Riset Ilmu Farmasi dan Kesehatan
Publisher : Asosiasi Riset Ilmu Kesehatan Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.61132/obat.v4i6.2628

Abstract

Ischemic stroke is a leading cause of mortality and disability, requiring complex therapy tailored to etiology, clinical condition, and risk factors, which increases the risk of irrational drug use and may affect clinical outcomes. Objective: This study identified patient characteristics, described medication utilization patterns, evaluated therapy rationality, and analyzed factors associated with clinical outcomes in ischemic stroke patients at the Inpatient Unit of Dr. Moewardi Hospital, Surakarta. Methods: This retrospective observational analytic study used medical record data, with samples selected by total sampling; among 109 records reviewed, 92 met inclusion criteria. Data were analyzed using the Chi-square test or Fisher's Exact Test (p<0.05). Results:. The most frequent therapy was antiplatelet combined with neuroprotective agents (48.9%), while rational therapy was found in 60 patients (65.2%). Most patients had improved clinical outcomes based on Glasgow Coma Scale (GCS) changes (87 patients, 94.6%). Bivariate analysis showed that pneumonia (p=0.045), seizures (p<0.001), consciousness level on admission (p<0.001), and therapy patterns (p=0.001) were significantly associated with clinical outcomes, while other factors showed no significant association (p>0.05). Conclusion: Most patients experienced improved clinical outcomes. Pneumonia, seizures, consciousness level, and therapy utilization patterns were associated with outcomes, whereas medication rationality was not significantly associated with clinical outcomes.
Hubungan Medication Beliefs dengan Kualitas Hidup pada Pasien Diabetes Melitus Tipe 2 di Puskesmas Kemalang Klaten 2026 Muryanti Muryanti; Niken Luthfiyanti; Rahmat Hidayat
OBAT: Jurnal Riset Ilmu Farmasi dan Kesehatan Vol. 4 No. 6 (2026): November: OBAT: Jurnal Riset Ilmu Farmasi dan Kesehatan
Publisher : Asosiasi Riset Ilmu Kesehatan Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.61132/obat.v4i6.2630

Abstract

Background: Type 2 diabetes mellitus requires long-term treatment and self-management. Patients’ beliefs about medication necessity and concerns may influence treatment behavior, but their relationship with quality of life may vary across populations. Objective: This study examined the relationship between medication beliefs and quality of life among patients with type 2 diabetes mellitus at Kemalang Public Health Center, Klaten, in 2026. Methods: An analytical quantitative approach with a cross-sectional design was employed, involving 78 respondents who satisfied the inclusion criteria and were recruited through purposive sampling. The 10-item Beliefs about Medicines Questionnaire (BMQ) was used to measure medication beliefs, whereas quality of life was evaluated using the WHOQOL-BREF instrument. A p-value below 0.05 was considered statistically significant. Results: The sample was predominantly composed of individuals aged 36-60 years (57.7%) and female participants (73.1%). Positive medication beliefs were observed in the majority of respondents (82.1%), while the necessity and concern belief dimensions were largely categorized as moderate, at 79.5% and 87.2% respectively. Good quality of life was reported by 75.6% of participants, although clinical outcomes remained uncontrolled in 74.4% of cases. Bivariate testing revealed no statistically significant association between medication beliefs and quality of life (LR=1.722; p=0.787). Conclusion: No significant relationship was found between medication beliefs and quality of life. This suggests quality of life is a multidimensional construct likely shaped by clinical, psychological, behavioral, and social factors extending beyond medication beliefs.
Co-Authors Adelino Gusmao Adliah Suci Rahmadani Afina Rachmalia Artha Aryasuta Afnisyah Nurcahyati Agustina, Isnaini Al Hajar Fuadatus Zurroh Alia Riski Andriyani AM, Ady Irawan Amanah Saputri, Yonafara Ana Yuliana Angelina da Costa Fernandes Anna Fitriawati Anna Fitriawati Annie Rahmatillah Aprilia Puteri Santika Apriliawan, Hidayah Apriliya, Intan Ardi Setyawan Ardi Setyawan Ayu Cahyani Abidin Bagas Ardiyantoro Bangkit Riska Permata Bangkit Riska Permata Burhannudin Ichsan Danang Raharjo Darah Ifalahma devitasari, Devitasari Dinda Herawati Diyana Hasna Afifah Endang Suciati Fachry Harbipero Fransiska Luciana Putri Handayani, Yessa Octavia Hidayah Apriliawan Intan Oktaviana Putri Iza Zulfa Salsabila Jayak Pratama, Kharisma Kharisma Jayak Pratama Kharisma Jayak Pratama Kharisma Jayak Pratama Khasanah, Isna Nur Khusain, Muhammad Fuad Zidane Kristanti Prihatin Sri Rejeki, Melinia Mega Larasati, Karina Dwi Listyani, Tiara Ajeng Malinda Apriliani Meli Oktavia Muhammad Fuad Zidane Khusain Muktamaroh, Anif Muryanti Muryanti NOVIANA Noviana Noviana Nugrahaeni Ayuningtyas Oktafia Nur Fatimah Oktaviani, Frida Indar Pratama, Kharisma Jayak Putri Eka Prasetya Rahmasari, Ikrima Rahmat Hidayat Rahmatillah, Annie Rohmana, Vivin Marwiyati S.A, Kusumaningtyas Safitri, Ayu Dwi Sahra fasa Nur Rohmah Setyaningrum, Fidya Shela Novita Devi Silvia Mawardani Siti Fathonah Wulandari Siwi Artini, Kusumaningtyas Siwi, Melati Daru Sudarsih, Dyah Ayu Suharjaya, Feby Nuranawati Tiara Ajeng L Tri Nofita Wulandari Tri Novita Wulandari Vanesha Aida Rahma Viona Vivin Marwiyati Vivin Marwiyati Rohmana Wardani, Lydia Puspita Wardani, Tatiana Siska Wulandari, Anggy